Trial-selective effects of U50,488H, a κ-opioid receptor agonist, on consummatory successive negative contrast

Behavioural Brain Research

Volumn 193, Issue 1, 2008, Pages 28-36

  Wood, Michael D ^a   Norris, Jacob N ^a   Daniel, Alan M ^a   Papini, Mauricio R ^a  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

Allocentric memory; Conditioned taste aversion; Consummatory behavior; Egocentric memory; Incentive contrast; Opioid system; U50,488H

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST;

ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONSUMMATORY SUCCESSIVE NEGATIVE CONTRAST; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; MALE; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE AVERSION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; BEHAVIOR, ANIMAL; CONSUMMATORY BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, KAPPA;

EID: 47849103271     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.04.016     Document Type: Article

References (53)

1. Ågmo A., and Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology 37 (1998) 223-232
2. Ågmo A., Galvan A., Heredia A., and Morales I. Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review. Psychopharmacology 120 (1995) 186-194
3. Amsel A. Frustration theory (1992), Cambridge University Press, Cambridge p. 278
4. Badiani A., Rajabi H., Nencini P., and Stewart J. Modulation of food intake by the k-opioid U50,488H: evidence for an effect on satiation. Behav Brain Res 118 (2001) 179-186
5. Bhargava H.N., and Thorat S.N. Effect of dizocilpine (mk-801) on analgesia and tolerance induced by U50,488H, a kappa-opioid receptor agonist, in the mouse. Brian Res 649 (1994) 111-116
6. Bentosela M., Ruetti E., Muzio R.N., Mustaca A.E., and Papini M.R. Administration of corticosterone after the first downshift trial enhances consummatory successive negative contrast. Behav Neurosci 120 (2006) 371-376
7. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264 (1993) 489-495
8. Bolanos C.A., Gabrielle M.G., Clair M.A., and McDougall S.A. Effects of the kappa opioid receptor agonist U50,488H on morphine-induced place preference conditioning in the developing rat. Eur J Pharmacol 317 (1996) 1-8
9. Cancela L.M., Bregonzio C., and Molina V.A. Anxiolytic-like effect induced by chronic stress is reversed by naloxone pretreatment. Brain Res Bull 36 (1995) 209-213
10. Cannon D.S., Best M.R., and Batson J.D. Taste familiarity and apomorphine-induced taste aversion. Behav Res Ther 21 (1983) 669-673
11. Crespi L.P. Quantitative variation in incentive and performance in the white rat. Am J Psychol 40 (1942) 467-517
12. Daniel AM, Papini MR. Trial-selective effects of the benzodiazepine anxiolytic chlordiazepoxide on consummatory successive negative contrast, submitted for publication.
13. Drewnowski A., Krahn D.D., Nairn K., and Gosnell B.A. Stealing in eating disordered patients. J Clin Psych 52 (1991) 112-115
14. Fanselow M.S., Kim S.L., Young D.J., Calcagnetti J.P., DeCola F.J., Helmstetter F.J., et al. Differential effects of selective opioid peptide antagonists on the acquisition of pavlovian fear conditioning. Peptides 12 (1991) 1033-1037
15. Flaherty C.F. Incentive relativity (1996), Cambridge University Press, Cambridge p. 227
16. Flaherty C.F., Grigson P.S., and Rowan G.A. Chlordiazepoxide and the determinants of contrast. Anim Learn Behav 14 (1986) 315-321
17. Gallagher M., and Kapp B.S. Manipulation of opiate activity in the amygdala alters memory processes. Life Sci 23 (1978) 1973-1977
18. Gray J.A. The psychology of fear and stress (1987), Cambridge University Press, Cambridge p. 256
19. Grigson P.S., Spector A.C., and Norgren R.N. Lesions of the pontine parabrachial nuclei eliminate successive negative contrast effects in rats. Behav Neurosci 108 (1994) 714-723
20. Henry L.J., Walker J., and Marjules D.L. Opposite effects of opiate agonists on metabolic weight loss in mice. Neuropeptides 5 (1985) 327-330
21. Hiramatsu M., Hyodo T., and Kameyama T. U50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur J Pharmacol 315 (1996) 119-135
22. Ilyutchenok R.Y., and Dubrovina N.I. Memory retrieval enhancement by kappa opioid agonist and mu, delta antagonists. Pharmacol Biochem Behav 52 (1995) 683-687
23. Kirk R.E. Experimental design: procedures for the behavioral sciences (1968), Brooks/Cole, Belmont p. 577
24. Kõks S., Soosaar A., Võikar V., Volke V., Ustav M., Männistö P.T., et al. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze. Neuropeptides 32 (1998) 235-240
25. Lett B.T. The painlike effect of gallamine and naloxone differs from sickness induced by lithium chloride. Behav Neurosci 99 (1988) 145-150
26. Li C.S., Davis B.J., and Smith D.V. Opioid modulation of taste responses in the nucleus of the solitary tract. Brain Res 965 (2003) 21-34
27. Lynch W.C., and Burns G. Opioid effects on intake of sweet solutions depend both on prior drug experience and on prior ingestive experience. Opioid effects on intake of sweet solutions depend both on prior drug experience and on prior ingestive experience. Appetite 15 (1990) 23-32
28. Mansour A., Hoversten M.R., Taylor L.P., Watson S.J., and Akil H. The cloned m, d and k receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res 700 (1995) 89-98
29. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8 (1995) 283-305
30. McDaniel K.L., Mundy W., Tilson H.A., and Hugh A. Microinjection of dynorphin into the hippocampus impairs spatial learning in rats. Pharmacol Biochem Behav 35 (1990) 429-435
31. McDonald R.V., Parker L.A., and Siegel S. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. Pharmacol Biochem Behav 58 (1997) 1003-1008
32. Mustaca A.E., Freidin E., and Papini M.R. Extinction of consummatory behavior in rats. Int J Comp Psychol 15 (2002) 1-10
33. Narita M., Suzuki T., Misawa M., and Nagase H. Antagonism of the morhine-induced Straub tail reaction by kappa-opioid receptor activation in mice. Psychopharmacology 110 (1993) 254-256
34. Nazarian A., Krall C.M., Osburn J.R., and McDougall S.A. Ultrasonic vocalizations of preweanling rats: Involvement of both alpha 2 adrenoceptor and kappa opioid receptor systems. Eur J Pharmacol 415 (2001) 165-171
35. Nemmani K.V., and Romarao P. Ginseng total saponin potentiates acute U50,488H-induced analgesia and inhibits tolerance to U50,488H-induced analgesia in mice. Pharmacol Biochem Behav 72 (2002) 1-6
36. Norris JN, Daniel AM, Papini MR. Spontaneous recovery of consummatory behavior, but not of consummatory successive negative contrast. Learn Motiv, in press.
37. Nunnink M., Davenport R.A., Ortega B., and Houpt T.A. D-cycloserine enhances conditioned taste aversion learning in rats. Pharmacol Biochem Behav 87 (2007) 321-330
38. Osaki M.Y., Castellan-Baldan F., Calvo A.D., Felippotti T.T., de Oliveira R., Ubiali W.A., et al. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of μ1 and κ opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus. Brain Res 992 (2003) 179-192
39. Papini M.R. Comparative psychology of surprising nonreward. Brain Behav Evol 62 (2003) 83-95
40. Papini M.R., Wood M., Daniel A.M., and Norris J.N. Reward loss as psychological pain. Int J Psychol Psychol Ther 6 (2006) 189-213
41. Pearl S.M., and Glick S.D. Prolonged antagonism of morphine-induced locomotor stimulation by κ opioid agonists: enhancement by prior morphine exposure. Neurosci Lett 212 (1996) 5-8
42. Pellegrini S., and Mustaca A.E. Consummatory successive negative contrast with solid food. Learn Motiv 31 (2000) 200-209
43. Pellegrini S., Wood M.D., Daniel A.M., and Papini M.R. Opioid receptors modulate recover from consummatory successive negative contrast. Behav Brain Res 164 (2005) 239-249
44. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 13 (1985) 149-167
45. Privette T.H. Involvement of the hippocampal kappa opioid system in anxiety. Diss Abs Int: Section B: Sci Eng 56 (1995) 560
46. Rowan G.A., and Flaherty C.F. Effect of morphine on negative contrast in consummatory behavior. Psychopharmacology 93 (1987) 51-58
47. Saper C.B., and Loewy A.D. Efferent connections of the parabrachial nucleus in the rat. Brain Res 197 (1980) 291-317
48. Schulties G., Martinez J.L., and Hruby V.J. Stimulation and antagonism of opioid delta-receptors produce opposite effects on active avoidance conditioning in mice. Behav Neurosci 102 (1988) 678-686
49. Schnur P., and Walker J.M. Effects of U50,488H on locomotor activity in the hamster. Pharmacol Biochem Behav 36 (1990) 813-816
50. Tabuchi E., Yokawa T., Mallick H., Inubushi T., Kondoh T., Ono T., et al. Spatio-temporal dynamics of brain activated regions during drinking behavior in rats. Brain Res 951 (2002) 270-279
51. Taylor C.C., Wu D.L., Soong Y., Yee J.S., and Szeto H.H. Kappa-opioid agonist, U50,488H stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor. J Pharmacol Exp Ther 277 (1996) 877-884
52. Walker J.M., Thompson L.A., Frascella J., and Friederich M.W. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur J Pharmacol 134 (1987) 53-59
53. Wood M.D., Daniel A.M., and Papini M.R. Selective effects of the δ-opioid receptor agonist DPDPE on consummatory successive negative contrast. Behav Neurosci 119 (2005) 446-454